Company · Ownership research

Candel Therapeutics, Inc. CADL

CIK 0001841387

Form 4 transactions dated Nov 1, 2023 to Nov 11, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 38 rows; the complete set is available through the API.

Insider filings on file run through Nov 5, 2026.

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Insider purchases & sales

Purchased: $10.50M
Sold: $7.69M

Nov 1, 2023 – Nov 5, 2026
Available records · partial months are marked ·

202510 of 18 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Jul 28, 2025	Nichols William Garrett Chief Medical Officer	Sale10b5-1 footnote	$6.54K 937 shares sold	1.75% sold Direct holding	▾
Jun 30, 2025	Nichols William Garrett Chief Medical Officer	Sale10b5-1 footnote	$3.94K 781 shares sold	1.47% sold Direct holding	▾
Mar 19, 2025	Tak Paul Peter Chief Executive Officer · Director	Sale10b5-1 footnote	$3.60K 400 shares sold	0.18% sold Direct holding	▾
Mar 18, 2025	Nichols William Garrett Chief Medical Officer	Sale10b5-1 footnote	$397.00K 45,316 shares sold	46.33% sold Direct holding	▾
Mar 18, 2025	Barone Francesca Chief Scientific Officer	Sale10b5-1 footnote	$281.67K 32,146 shares sold	24.98% sold Direct holding	▾
Mar 18, 2025	Tak Paul Peter Chief Executive Officer · Director	Sale10b5-1 footnote	$226.02K 25,772 shares sold	10.23% sold Direct holding	▾
Mar 17, 2025	Tyagarajan Seshu Chief Technology Officer	Sale10b5-1 footnote	$275.95K 31,278 shares sold	26.78% sold Direct holding	▾
Mar 17, 2025	Schoch Charles See Remarks	Sale10b5-1 footnote	$44.17K 5,000 shares sold	11.62% sold Direct holding	▾
Jan 15, 2025	Tyagarajan Seshu Chief Technology Officer	Sale	$103.48K 14,322 shares sold	12.89% sold Direct holding	▾
Jan 15, 2025	Barone Francesca Chief Scientific Officer	Sale	$97.78K 13,534 shares sold	10.90% sold Direct holding	▾

Showing 18 / 18 record groups in 2025. The complete set is available through the API.

Candel Therapeutics, Inc. · CADL

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 18 of 18 purchase / sale groups and 30 of 38 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"CADL","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.